Stock Surge: Hologic, Inc. (HOLX) Closes at 74.86, Marking a -1.04 Increase/Decrease

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

In the latest session, Hologic, Inc. (NASDAQ: HOLX) closed at $74.86 down -1.04% from its previous closing price of $75.65. In other words, the price has decreased by -$1.04 from its previous closing price. On the day, 1.62 million shares were traded. HOLX stock price reached its highest trading level at $76.44 during the session, while it also had its lowest trading level at $74.81.

Ratios:

For a deeper understanding of Hologic, Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.01 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.41. For the most recent quarter (mrq), Quick Ratio is recorded 3.29 and its Current Ratio is at 3.97. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.52.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on April 03, 2024, Upgraded its rating to Buy and sets its target price to $95 from $80 previously.

On July 14, 2023, Needham Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $95.

On December 07, 2022, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $75.RBC Capital Mkts initiated its Sector Perform rating on December 07, 2022, with a $75 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 14 ’24 when GARRETT SCOTT T sold 16,441 shares for $75.50 per share. The transaction valued at 1,241,296 led to the insider holds 48,611 shares of the business.

CRAWFORD SALLY sold 9,039 shares of HOLX for $690,607 on Mar 08 ’24. The Director now owns 132,927 shares after completing the transaction at $76.40 per share. On Mar 08 ’24, another insider, Dockendorff Charles J, who serves as the Director of the company, sold 1,465 shares for $76.21 each. As a result, the insider received 111,648 and left with 1,572 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOLX now has a Market Capitalization of 17470601216 and an Enterprise Value of 17851197440. As of this moment, Hologic,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.51, and their Forward P/E ratio for the next fiscal year is 16.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.41 while its Price-to-Book (P/B) ratio in mrq is 3.61. Its current Enterprise Value per Revenue stands at 4.507 whereas that against EBITDA is 14.607.

Stock Price History:

The Beta on a monthly basis for HOLX is 1.01, which has changed by -0.07648653 over the last 52 weeks, in comparison to a change of 0.2644323 over the same period for the S&P500. Over the past 52 weeks, HOLX has reached a high of $83.13, while it has fallen to a 52-week low of $64.02. The 50-Day Moving Average of the stock is -1.81%, while the 200-Day Moving Average is calculated to be 2.42%.

Shares Statistics:

For the past three months, HOLX has traded an average of 1.62M shares per day and 1479850 over the past ten days. A total of 241.71M shares are outstanding, with a floating share count of 229.78M. Insiders hold about 1.54% of the company’s shares, while institutions hold 98.84% stake in the company. Shares short for HOLX as of 1714435200 were 4575889 with a Short Ratio of 2.83, compared to 1711584000 on 4442052. Therefore, it implies a Short% of Shares Outstanding of 4575889 and a Short% of Float of 2.94.

Earnings Estimates

The market rating of Hologic, Inc. (HOLX) is currently shaped by the ongoing analysis conducted by 14.0 analysts closely monitoring its performance.On average, analysts expect EPS of $1.02 for the current quarter, with a high estimate of $1.04 and a low estimate of $0.99, while EPS last year was $0.93. The consensus estimate for the next quarter is $1.04, with high estimates of $1.06 and low estimates of $1.02.

Analysts are recommending an EPS of between $4.11 and $4.03 for the fiscal current year, implying an average EPS of $4.07. EPS for the following year is $4.44, with 17.0 analysts recommending between $4.55 and $4.31.

Revenue Estimates

For the next quarter, 13 analysts are estimating revenue of $1B. There is a high estimate of $1.01B for the next quarter, whereas the lowest estimate is $989.2M.

A total of 16 analysts have provided revenue estimates for HOLX’s current fiscal year. The highest revenue estimate was $4.04B, while the lowest revenue estimate was $4.02B, resulting in an average revenue estimate of $4.03B. In the same quarter a year ago, actual revenue was $4.03BBased on 16 analysts’ estimates, the company’s revenue will be $4.25B in the next fiscal year. The high estimate is $4.35B and the low estimate is $4.16B.

Most Popular

[the_ad id="945"]